Latest News & Updates

Breaking News

  • 16 hours ago

  • Simantini Singh Deo

Inside The Mind Of A Vaccine Manufacturing Leader: Rakesh Kumar Sinha Of Biological E Shares Insights On Quality, Leadership, And Innovation
Breaking News
Precision Neuroscience Expands Leadership Team With Key Hires From Meta & FDA: Vanessa Tolosa Named Senior Vice President Of R&D and Vivek Pinto Appointed Director of Medical Affairs

Simantini Singh Deo

Quality, Leadership, & Global Impact: A Candid Conversation With Former Wockhardt President Pradnya Deshmukh

Simantini Singh Deo

FABA’s Finishing School Sets a New Benchmark for Life Sciences Training in India

Ravindra Warang

Sernova Appoints CEO Jonathan Rigby As Interim Chair Amid Financing Talks And Executive Changes

Vaibhavi M.

Other trending news you may like to read

Merck Begins Global Phase 3 Trial For Investigational Dengue Vaccine

Merck begins Phase 3 trial of V181 dengue vaccine, aiming for single-dose protection across all four serotypes.

Vaibhavi M.

Article

Novo Nordisk Advances Subcutaneous And Oral Amycretin to Phase 3 for Obesity Management

Novo Nordisk to advance subcutaneous and oral amycretin into Phase 3 trials for weight management.

Vaibhavi M.

Article

Novartis’ Fabhalta® Delivers Sustained Efficacy And Safety In PNH Patients Switching from Anti-C5 Therapies

Novartis reports strong Phase IIIB results for Fabhalta in PNH patients switching from anti-C5 therapies.

Vaibhavi M.

Article

Starton Therapeutics Opens Enrollment For Phase 2a Trial Of STAR-LLD, A Continuous Low-Dose Lenalidomide Therapy For Multiple Myeloma

Starton begins Phase 2a trial of STAR-LLD in multiple myeloma with first patients enrolled in Ohio and North Carolina.

Simantini Singh Deo

Article